MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rheumatology/keaf075

Медицинская библиотека · Rheumatology (Oxford, England) · 2025

Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD).

Thoreau Benjamin, Renaud Arthur, Chafey Philippe, Clary Guilhem, Le Gall Morgane, Broussard Cédric, Launay Odile, Launay David, Hachulla Eric, Deligny Christophe, Baruteau Alban-Elouen, Vallet-Pichard Anaïs, Chaigne Benjamin, Yaici Azzeddine, Sitbon Olivier, Montani David, Humbert Marc, Mouthon Luc

Clinical StudyСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Pulmonary arterial hypertension (PAH) is a rare disease that may be associated with CTD. Anti-fibroblast (AFA) and AECA have been identified in idiopathic and SSc-associated PAH. The aim was to identify autoantibodies discriminating for PAH associated with SLE, MCTD and primary SS, and their target antigens.

METHODS

Sera were collected in the French multicentre auto-HTAP study from 86 patients with CTD excluding SSc, including 32 with PAH (PAH+) and 54 without (PAH-). AFA and AECA were identified using one- (1D) and two-dimensional (2D) immunoblots and proteomics. ELISA tests using human recombinant proteins were used to confirm PAH-associated IgG reactivities.

RESULTS

PAH+ patients had similar IgG AFA and AECA reactivities in 56.2% and 40.6% of the cases in 1D immunoblots, respectively. In 2D immunoblots, serum IgG pools from SLE patients (n = 14), MCTD (n = 10), SS (n = 9) and 14 healthy controls (n = 1) recognized, respectively, 273 ± 79, 205 ± 77, 109 ± 11 and 109 protein spots in fibroblasts and 189 ± 48, 146 ± 30, 88 ± 33 and 190 protein spots in endothelial cell extracts. Serum IgG from PAH+ patients recognized 39 fibroblast and 34 endothelial cell protein spots that were not recognized by IgG from PAH- patients, including Annexin A5 (ANXA5). Anti-ANXA5 IgG reactivity was significantly higher in PAH+ compared with PAH- patients with MCTD (73% vs 0%, P < 0.001) and SLE (33% vs 0%, P = 0.009).

CONCLUSION

Anti-ANXA5 IgG autoantibody reactivity might represent a predictive biomarker for PAH associated with MCTD and SLE.

Для цитирования: Thoreau Benjamin, Renaud Arthur, Chafey Philippe, Clary Guilhem, Le Gall Morgane, Broussard Cédric, Launay Odile, Launay David, Hachulla Eric, Deligny Christophe, Baruteau Alban-Elouen, Vallet-Pichard Anaïs, Chaigne Benjamin, Yaici Azzeddine, Sitbon Olivier, Montani David, Humbert Marc, Mouthon Luc. Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD).. Rheumatology (Oxford, England). 2025. DOI: 10.1093/rheumatology/keaf075.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.